pymnts.com

Teva Under Antitrust Scrutiny in Turkey Over Copaxone Claims

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries
Sig3.02Sen-4.85Env0.00Soc0.00Gov-5.78

Turkish regulators are separately examining whether Teva created a potentially misleading picture for health authorities on the safety and effectiveness of rival medicines, Fierce Pharma reported. Teva said the inquiry is at the investigative stage and concerns a longstanding Copaxone antitrust dispute, noting it resembles an EU case. The report recalls a 2024 EU fine of €462.6M and earlier US False Claims Act allegations resolved by criminal and civil agreements.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro